MedPath

A clinical trail on managment of Diabetes Mellitus by using Uranium Nitricum

Phase 3
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2021/12/039033
Lead Sponsor
Perla Sai Bhuvaneshwari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient who fulfilling the case definition.

2. Patient who are willing to take treatment and will co-operate with regular follow up.

3. HbA1c level of patient should be above 6.5 %-9%

4. Patients with pre-diagnosed case of diabetes mellitus by physician.

5. Patients of both sexes.

6. Patients who signed the consent form.

7. Diabetes seen in post covid patients.

Exclusion Criteria

1. Patient who has not the signed consent.

2.Patients needed with emergency medical intervention with complication of systemic

diseases.

3. Patients with diabetic complications will not be included.

4. Gestational diabetes is excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath